3 month semaglutide results GLP-1 Weight Loss I'm so proud of my

On December 23, 2024, the FDA approved the first generic Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor agonist.

If EMA approval lands in 2H 2026 and supply scales smoothly, Novo could solidify leadership in the fastest-growing segment of metabolic medicine

That is the conclusion of a retrospective study published online on Jan

These observations, while compelling, are hypothesis-generating and require prospective validation before informing clinical use

Some sub-analyses of large clinical trials suggest that GLP-1RA and sodium-glucose cotransporter 2 inhibitor combination therapy may provide more significant reductions in heart failure hospitalization and renal composite events than each alone

Semaglutide is a medication commonly used for the treatment of type 2 diabetes and obesity